Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis. Case Rep Rheumatol 2016;2016:7906013
Date
06/14/2016Pubmed ID
27293946Pubmed Central ID
PMC4879227DOI
10.1155/2016/7906013Abstract
Eosinophilic fasciitis (EF) is a rare disorder involving chronic inflammation of the fascia and connective tissue surrounding muscles, nerves, and blood vessels. While its pathogenesis is not entirely understood, this disorder is thought to be autoimmune or allergic in nature. We present here a case of a 59-year-old male who developed peripheral eosinophilia and subsequent eosinophilic fasciitis during treatment with infliximab. To our knowledge, eosinophilic fasciitis has not been previously described in patients during treatment with an inhibitor of tumor necrosis factor α.
